| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/12/2003 | EP1200824A4 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives |
| 03/12/2003 | EP0937726B1 Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates |
| 03/12/2003 | EP0789577B1 Synthesis of n-substituted oligomers |
| 03/12/2003 | EP0763039B1 42-rapamycin hydroxyester, process for its preparation and pharmaceutical compositions containing it |
| 03/12/2003 | CN1402728A Method for producing epinastine hydrochloride in high-melting crystal modification |
| 03/12/2003 | CN1402727A Bicyclic imidazo-3-yl-amine derivs. which are substd. on sixth ring |
| 03/12/2003 | CN1402726A Bicyclic imidazo-5-yl-amine derivs. |
| 03/12/2003 | CN1402724A Thiazolidinedione derivs. as antidiabetic agents |
| 03/12/2003 | CN1401647A High specific rotatory power levoleucovorin calcium and resolution method thereof |
| 03/11/2003 | US6531601 Comprising an amorphous silica binder and crystalline aluminosilicate, e.g. zeolite ZSM-5 having an oxygen ten-membered ring structure; hardness; efficiency; high strength; durability; mixing and molding |
| 03/11/2003 | US6531487 Water solubility; bioavailability |
| 03/11/2003 | US6531477 Treating cancer or other proliferative diseases |
| 03/11/2003 | US6531475 Corticotropin-releasing factor receptor antagonists |
| 03/11/2003 | US6531468 Inhibiting serotonin reuptake in the central nervous system of a mammal |
| 03/06/2003 | WO2003019621A2 Convergent synthesis of multiporphyrin light-harvesting rods |
| 03/06/2003 | WO2003018587A1 Helix mimetics and composition and methods related thereto |
| 03/06/2003 | WO2003018586A1 Substituted-aryl 7-aza[2.2.1]bicycloheptanes for the treatment of disease |
| 03/06/2003 | WO2003018585A1 Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease |
| 03/06/2003 | WO2003018584A1 Intermediates for synthesis of vinblastines, process for preparation of the intermediates and process for synthesis of vinblastines |
| 03/06/2003 | WO2003018583A1 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid |
| 03/06/2003 | WO2003018563A1 Anti-inflammatory and protein kinase inhibitor composition and method of use |
| 03/06/2003 | WO2003018548A2 Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof |
| 03/06/2003 | WO2003018020A1 Jnk inhibitors |
| 03/06/2003 | WO2003018007A1 Antitumor agents and process for producing the same |
| 03/06/2003 | WO2003017846A1 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy |
| 03/06/2003 | WO2003017764A1 Substituted propargylamines |
| 03/06/2003 | WO2003000240A3 Stable powder inhalation dosage formulation |
| 03/06/2003 | WO2002094830A3 DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS |
| 03/06/2003 | WO2002072570A3 Non-imidazole compounds as histamine h3 antagonists |
| 03/06/2003 | WO2002047671A3 Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 03/06/2003 | US20030045546 Anticancer agents |
| 03/06/2003 | US20030045536 Compounds specific to adenosine A1 receptors and uses thereof |
| 03/06/2003 | US20030045532 Triazolo-pyrimidine derivatives as ligands for gaba receptors |
| 03/06/2003 | US20030045528 Antibacterial and antiprotozoal agents |
| 03/06/2003 | CA2458600A1 Intermediates for synthesis of vinblastines, process for preparation of the intermediates and process for synthesis of vinblastines |
| 03/06/2003 | CA2458375A1 Substituted-heteroaryl-7-aza¬2.2.1|bicycloheptanes for the treatment of disease |
| 03/06/2003 | CA2458131A1 Jnk activation inhibitor |
| 03/06/2003 | CA2457589A1 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy |
| 03/06/2003 | CA2455773A1 Substituted-aryl 7-aza¬2.2.1|bicycloheptanes for the treatment of disease |
| 03/05/2003 | EP1288216A1 Tricyclic quinazolinediones |
| 03/05/2003 | EP1288205A1 Novel phenylalanine derivatives |
| 03/05/2003 | EP1287011A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections |
| 03/05/2003 | EP1286997A1 6-phenylpyrrolopyrimidinedione derivatives |
| 03/05/2003 | EP1286995A1 2,7-naphthyridine derivatives |
| 03/05/2003 | EP1286984A2 Method for the preparation of tetrahydrobenzothiepines |
| 03/05/2003 | EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents |
| 03/05/2003 | EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents |
| 03/05/2003 | EP1026167B1 Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents |
| 03/05/2003 | EP0964865B1 Pharmaceutically active tricyclic amines |
| 03/05/2003 | EP0945438B1 Pyrazole derivatives |
| 03/05/2003 | EP0724457B1 Radiation sensitization using texaphyrins |
| 03/05/2003 | CN1400973A Novel biarylcarboxamides |
| 03/05/2003 | CN1400505A Image forming material and ammonium compound |
| 03/04/2003 | US6528659 Condensation between protected and unprotected pyrroles to form chemical intermediates; deprotecting; easier purifi-cation, isolation, storage and transportation |
| 03/04/2003 | US6528649 Imidazoloisoquinolines |
| 03/04/2003 | US6528646 Pyrrolo(2,3-c)azepin-8-one |
| 03/04/2003 | US6528230 Dye precursor, image forming material, and image forming method |
| 02/27/2003 | WO2003016316A1 Diazacycloalkanes as oxytocin agonists |
| 02/27/2003 | WO2003016315A1 Sodium salt of an hiv integrase inhibitor |
| 02/27/2003 | WO2003016314A1 1-alkyl 0r 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 02/27/2003 | WO2003016313A1 New compounds for treating impotence |
| 02/27/2003 | WO2003016302A1 Diamine derivatives |
| 02/27/2003 | WO2003016245A1 Chromatographic separation of enantiomers of protected amino acids via smb-method |
| 02/27/2003 | WO2003015785A1 2h-phthalazin-1-ones and methods for use thereof |
| 02/27/2003 | WO2002100862A3 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 02/27/2003 | WO2002098350A3 Pyranoindazoles and their use for the treatment of glaucoma |
| 02/27/2003 | WO2002092010A3 Reverse-turn mimetics and methods relating thereto |
| 02/27/2003 | WO2002087553A3 Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops |
| 02/27/2003 | WO2002085903A3 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 02/27/2003 | WO2002083064A3 A method of treating cancer |
| 02/27/2003 | WO2002067675A3 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides |
| 02/27/2003 | US20030040523 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 02/27/2003 | US20030040522 Process for the production of N-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-N-ethylacetamide (zaleplon) |
| 02/27/2003 | US20030040518 For therapy of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons degeneration of lesioned and damaged neurons |
| 02/27/2003 | US20030040517 For use in therapy of pain, fever, inflammation of a variety of conditions and diseases |
| 02/27/2003 | CA2456985A1 2h-phthalazin-1-ones and methods for use thereof |
| 02/27/2003 | CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors |
| 02/27/2003 | CA2456206A1 Sodium salt of an hiv integrase inhibitor |
| 02/27/2003 | CA2453962A1 Diazacycloalkanes as oxytocin agonists |
| 02/27/2003 | CA2453647A1 1-alkyl 0r 1-cycloalkyltriazolo¬4,3-a|quinazolin-5-ones as phosphodiesterase inhibitors |
| 02/26/2003 | EP1285922A1 1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 02/26/2003 | EP1284976A2 Diazabicyclic central nervous system active agents |
| 02/26/2003 | EP1284967A1 3-substituted isoquinolin-1-yl derivatives |
| 02/26/2003 | EP1042324B1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof |
| 02/26/2003 | EP1011726B1 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |
| 02/26/2003 | CN1399638A Indoloazepines as vasopressin receptor antagonists |
| 02/26/2003 | CN1399637A Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine and its prep. |
| 02/26/2003 | CN1399561A Conjugate having cleavable linkage for use in liposome |
| 02/25/2003 | US6525213 Esterification of alcohol with carboxylic acid, carboxylic acid chloride or carboxylic acid bromide in presence of acid adduct of 1,5-diazabicyclo(4.3.0)-non-2-ene or 1,8-diazabicyclo(5.4.0)-undec-7-ene |
| 02/25/2003 | US6525211 Herbicidal sulphonylamino(thio)carbonyl compounds |
| 02/25/2003 | US6525196 5HT1 antagonists for antidepressant therapy |
| 02/25/2003 | US6525193 Aminoaryl oxazolidinone N-oxides |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525067 Substituted heterocyclic derivatives |
| 02/25/2003 | US6525065 Pharmaceutical compositions and methods for effecting dopamine release |
| 02/25/2003 | US6525060 Triazolo(4,5-d)pyrimidine compounds |
| 02/25/2003 | US6525059 Substituted pyrazoles as p38 kinase inhibitors |
| 02/25/2003 | US6525056 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders |
| 02/25/2003 | US6525055 Allergic and inflammatory pathologies such as, for example, emphysema, chronic bronchitis, asthma and allergic rhinitis. |